This inventor holds 1 USPTO granted patent. Top assignee: E.i. Dupont De Nemours and Company. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Ahmad W Malick: Innovator in Pharmaceutical Composition
Introduction
Ahmad W Malick is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating cardiac disorders. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Ahmad W Malick holds a patent for a pharmaceutical composition and method of treatment or prophylaxis of cardiac disorders. The patent describes a composition that includes a short-acting β-blocking compound, which is formulated in a hydroalcoholic solution. This composition also contains a physiologically acceptable buffering agent, ethanol, and a liquid polyhydric compound. The invention aims to provide an effective method for treating or preventing cardiac disorders, showcasing Malick's commitment to advancing medical treatments.
Career Highlights
Ahmad W Malick is associated with E.I. du Pont de Nemours and Company, where he has been able to apply his knowledge and skills in pharmaceutical innovation. His work at this esteemed company has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research and development.
Collaborations
Throughout his career, Ahmad has worked alongside notable colleagues such as Dietmar M Wagenknecht and Agustin Escobar. These collaborations have enriched his research and have played a crucial role in the advancement of his projects.
Conclusion
Ahmad W Malick is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the treatment of cardiac disorders significantly. His innovative spirit and dedication to research continue to drive advancements in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
